Amber Johnson
0000-0002-6202-6113
5 papers found
Refreshing results…
Actionability classification of variants of unknown significance correlates with functional effect
Challenges and opportunities associated with the MD Anderson IMPACT2 randomized study in precision oncology
Somatic Genomic Testing in Patients With Metastatic or Advanced Cancer: ASCO Provisional Clinical Opinion
Emergence of mTOR mutation as an acquired resistance mechanism to AKT inhibition, and subsequent response to mTORC1/2 inhibition
Precision medicine: preliminary results from the Initiative for Molecular Profiling and Advanced Cancer Therapy 2 (IMPACT2) study
Missing publications? Search for publications with a matching author name.